Aequus Pharmaceuticals's market cap is currently C$663.17K. The company's EPS TTM is C$-0.02; its P/E ratio is ―; Aequus Pharmaceuticals is scheduled to report earnings on April 30, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	C$ 254.90K	C$ 1.38M	C$ 2.71M	C$ 2.59M	C$ 1.63M
Gross Profit	C$ 5.50K	C$ 1.15M	C$ 2.69M	C$ 2.59M	C$ 1.63M
Operating Income	C$ -2.82M	C$ -2.50M	C$ -1.35M	C$ -521.57K	C$ -2.21M
EBITDA	C$ -2.68M	C$ -2.87M	C$ -1.23M	C$ -314.80K	C$ -2.38M
Net Income	C$ -2.96M	C$ -3.21M	C$ -1.81M	C$ -1.05M	C$ -3.11M
Balance Sheet
Cash & Short-Term Investments	C$ 170.20K	C$ 294.67K	C$ 2.39M	C$ 1.72M	C$ 484.51K
Total Assets	C$ 1.09M	C$ 1.69M	C$ 4.35M	C$ 3.13M	C$ 1.67M
Total Debt	C$ 5.06M	C$ 782.92K	C$ 2.18M	C$ 2.32M	C$ 2.22M
Net Debt	C$ 4.89M	C$ 533.10K	C$ -211.31K	C$ 604.74K	C$ 1.73M
Total Liabilities	C$ 5.38M	C$ 3.07M	C$ 2.56M	C$ 2.56M	C$ 2.55M
Stockholders' Equity	C$ -4.29M	C$ -1.38M	C$ 1.79M	C$ 573.95K	C$ -877.09K
Cash Flow
Free Cash Flow	C$ -2.29M	C$ -1.95M	C$ -1.18M	C$ -817.23K	C$ -1.63M
Operating Cash Flow	C$ -2.29M	C$ -1.95M	C$ -1.17M	C$ -804.91K	C$ -1.63M
Investing Cash Flow	C$ 0.00	C$ 0.00	C$ -507.96K	C$ -12.32K	C$ -2.68K
Financing Cash Flow	C$ 2.21M	C$ -189.19K	C$ 2.40M	C$ 2.05M	C$ 1.75M

Currency in CAD

Aequus Pharmaceuticals Earnings and Revenue History

Income Statement >

Aequus Pharmaceuticals Debt to Assets

Balance Sheet >

Aequus Pharmaceuticals Cash Flow

Cash Flow >

Aequus Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing